Alivus Life Sciences Limited (BOM:543322)

Alivus Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 12, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	112,893	132,481	95,161	48,141	56,215	-
Market Cap Growth	-23.06%	39.22%	97.67%	-14.36%	-	-
Enterprise Value	106,969	128,178	90,913	44,570	52,405	-
Last Close Price	920.80	1073.88	771.20	376.40	408.72	-
PE Ratio	20.76	27.28	20.21	10.31	13.43	-
PS Ratio	4.49	5.55	4.17	2.23	2.65	-
PB Ratio	3.74	4.70	4.08	2.25	2.74	-
P/TBV Ratio	3.77	4.74	4.11	2.27	2.75	-
P/FCF Ratio	-	58.79	33.44	33.62	12.08	-
P/OCF Ratio	-	33.84	23.01	15.73	9.41	-
EV/Sales Ratio	4.26	5.37	3.98	2.06	2.47	-
EV/EBITDA Ratio	13.78	18.88	13.59	6.97	8.53	-
EV/EBIT Ratio	15.03	20.55	14.61	7.42	9.05	-
EV/FCF Ratio	-	56.88	31.95	31.12	11.26	-
Debt / Equity Ratio	0.02	0.02	0.01	0.01	0.00	1.24
Debt / EBITDA Ratio	0.08	0.08	0.03	0.03	0.00	1.57
Debt / FCF Ratio	-	0.25	0.06	0.14	0.01	2.91
Net Debt / Equity Ratio	-0.20	-0.17	-0.12	-0.12	-0.25	1.08
Net Debt / EBITDA Ratio	-0.77	-0.72	-0.42	-0.41	-0.83	1.37
Net Debt / FCF Ratio	-	-2.18	-1.00	-1.85	-1.09	2.54
Asset Turnover	-	0.76	0.82	0.84	0.95	1.01
Inventory Turnover	-	1.69	1.64	1.87	2.07	2.02
Quick Ratio	-	3.31	2.64	2.34	3.10	0.66
Current Ratio	-	4.97	4.37	3.73	4.60	1.15
Return on Equity (ROE)	-	18.86%	21.07%	22.28%	29.83%	60.91%
Return on Assets (ROA)	-	12.45%	14.01%	14.52%	16.20%	18.86%
Return on Invested Capital (ROIC)	21.98%	21.18%	23.67%	26.11%	27.58%	27.79%
Return on Capital Employed (ROCE)	-	21.20%	25.80%	27.20%	27.70%	72.40%
Earnings Yield	4.82%	3.67%	4.95%	9.70%	7.45%	-
FCF Yield	-	1.70%	2.99%	2.97%	8.28%	-
Dividend Yield	0.54%	0.47%	2.92%	5.58%	5.14%	-
Payout Ratio	-	-	58.55%	82.64%	30.73%	-
Buyback Yield / Dilution	-0.01%	-0.17%	-0.13%	-4.25%	-9.03%	-
Total Shareholder Return	0.52%	0.30%	2.79%	1.33%	-3.89%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.